We deliver on your promises

Optimapharm is a globally operating, leading, mid-sized, full-service CRO aiming to deliver new therapies to improve and save patients’ lives. 

Oncology clinical trials expertise
Rare Diseases clinical trials expertise
Why perform clinical trials in Nordics & Baltics

Whether a pharmaceutical, biotech or medical device company, we are your ideal mid-sized, full-service CRO.
Our in-depth expertise and long lasting experience combined with a flexible, and collaborative approach allow us to tailor our responses to each individual study.

Our clinical development capabilities span through trial Phases I-IV, across a broad range of therapeutic areas including medical devices.
We have an excellent track record for supporting a range of stakeholders in the pharmaceutical industry including sponsors and research institutions at each clinical development phase.

DOWNLOAD OUR BROCHURE

1700

completed
projects

85

repeat
business

88

positive
recommendation

8

site inspections
from EMA/FDA completed

Tailor-made solutions

Your effective and rigorously compliant project strategy will be tailor-made to the specific requirements of your clinical trial. Our flexibility in project design and implementation, based on our in-house expertise and experience is backed up by delivering full-service with deep expertise.

Your Regulatory and Operational Local Expert

Our highly experienced local regulatory and operational experts located in 40 countries throughout Europe and North America to support any strategic questions to optimize your design and the delivery of your project.

Delivery focused

A proud track record of accelerated start-up timelines, over-achievement of recruitment targets, early completions and cost competitive budgetary adherence demonstrates that we are extremely focused at running efficient and effective clinical trials.

Shared goals

You need a CRO partner who is as invested in the success of each bespoke clinical trial as you are. We collaborate closely, constantly making sure that we are aligned with your study expectations and key study milestones. Essentially, we become an extended arm to your team with the same shared goals.

Pharmaceutical companies
Delivery-focused bespoke solutions for all phases of drug development.
Biotechnology enterprises
Dedicated service and expertise that delivers high-quality, cost-effective results.
Medical Device companies
Smart solutions built on a combination of regulatory expertise and deep understanding of project specificities.

News

March 27, 2024 in News

CTIS: First Optimapharm Experiences, an Interview with Sara Weytjens

CTIS – First Optimapharm Experiences, an Interview with Sara Weytjens In recent years, CTIS has become a major topic of discussion in the field of EU clinical research. The implementation of this system has completely transformed traditional practices and had…
Read More
October 4, 2023 in News

Optimapharm announces Jelena Pavlović as Senior Director, Trial Support

Optimapharm announces Jelena Pavlović as Senior Director, Trial Support Optimapharm, a leading, mid-sized, full-service CRO across Europe and North America, is excited to announce the appointment of Jelena Pavlović as Senior Director, Trial Support, effective August 2023 "It is such…
Read More
May 17, 2023 in News

Optimapharm announces Sara Weytjens as Vice President, Regulatory and Site Activation

Optimapharm announces Sara Weytjens as Vice President, Regulatory and Site Activation   Optimapharm, a leading, mid-sized, full-service CRO across Europe and North America, is excited to announce the appointment of Sara Weytjens as Vice President, Regulatory and Site Activation, effective April…
Read More
April 28, 2023 in News

Optimapharm confirms Mirna Šenjug Novak as Group CFO

Optimapharm confirms Mirna Šenjug Novak as Group CFO   Optimapharm, a leading, mid-sized, full-service CRO (Contract Research Organization) across Europe and North America, is excited to announce the promotion of Mirna Šenjug Novak as Group Chief Financial Officer (CFO), effective February…
Read More